首页> 外文期刊>Radiology >Hepatic Perfusion Disorder Associated with Focal Liver Lesions: Contrast-enhanced US Patterns--Correlation Study with Contrast-enhanced CT.
【24h】

Hepatic Perfusion Disorder Associated with Focal Liver Lesions: Contrast-enhanced US Patterns--Correlation Study with Contrast-enhanced CT.

机译:与局灶性肝病变相关的肝灌注障碍:对比增强的美国模式-对比增强CT的相关性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To retrospectively compare the detection and characterization of hepatic perfusion disorder (HPD) associated with focal liver lesions (FLLs) at contrast material-enhanced ultrasonography (US) by using contrast-enhanced computed tomography (CT) as the reference standard. Materials and Methods: The study was approved by the local institutional ethics committee, and informed consent was waived. Three hundred fifty patients (mean age, 50 years +/- 11 [standard deviation]; age range, 19-82 years; 168 women, 182 men) underwent contrast-enhanced US and contrast-enhanced CT between April 2008 and July 2010. Two independent readers reviewed contrast-enhanced US images for the detection and characterization of HPD. The largest lesion or the lesion best identified at contrast-enhanced US per patient was used for statistical analysis. Contrast-enhanced CT was used as the reference standard. Contrast-enhanced US and CT interreader agreement of diagnoses was assessed by using the weighted kappa coefficient, and influences of lesion size, enhancement covering rate, and liver cirrhosis were evaluated by using logistic regression analysis and the paired chi(2) test. Sensitivity, specificity, positive and negative predictive values, and accuracy of contrast-enhanced US for HPD detection were calculated. Results: Contrast-enhanced US results showed HPD features similar to those of CT imaging. CT depicted 50 HPDs in 350 patients, and contrast-enhanced US depicted 55 HPDs in 350 patients. The agreement for HPD diagnosis between US and CT was good (kappa = 0.749). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of contrast-enhanced US were 84.0%, 95.7%, 76.4%, 97.3%, and 0.945, respectively. Rapid enhancement coverage (P < .001) and lesion size (P = .002) were significant predictors of the occurrence of HPD. Liver cirrhosis did not have significant influence for HPD detection (P = .087). Image zooming, limited acoustic window, lesion diameter greater than 5 cm, attenuation, and blurred images were the main reasons for the false-positive diagnosis of HPD at contrast-enhanced US. Conclusion: The HPD in FLLs can reliably be detected with contrast-enhanced US, which correlated well with contrast-enhanced CT images. (c) RSNA, 2011 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11101454/-/DC1.
机译:目的:以造影剂增强型计算机断层扫描(CT)为参考标准,回顾性比较造影剂增强型超声检查(US)与局灶性肝病灶(FLL)相关的肝灌注异常(HPD)的检测和特征。资料和方法:该研究得到当地机构伦理委员会的批准,并放弃知情同意。在2008年4月至2010年7月期间,对350例患者(平均年龄为50岁+/- 11 [标准差];年龄范围为19-82岁; 168名女性,182名男性)进行了超声造影和增强CT检查。两名独立读者审阅了对比度增强的美国图像,以检测和表征HPD。每位患者在造影剂增强超声检查中发现的最大病变或最佳病变被用于统计分析。对比增强CT作为参考标准。通过加权kappa系数评估增强的US和CT阅读器间的对比诊断,并通过逻辑回归分析和配对的chi(2)检验评估病变大小,增强覆盖率和肝硬化的影响。计算灵敏度,特异性,阳性和阴性预测值和HPD检测对比增强US的准确性。结果:对比增强的美国结果显示HPD特征与CT成像相似。 CT显示350例患者中有50个HPD,而增强对比的US显示350例患者中有55个HPD。 US和CT之间的HPD诊断协议良好(kappa = 0.749)。对比增强US的敏感性,特异性,阳性预测值,阴性预测值和准确性分别为84.0%,95.7%,76.4%,97.3%和0.945。快速增强覆盖率(P <.001)和病变大小(P = .002)是HPD发生的重要预测指标。肝硬化对HPD检测没有显着影响(P = .087)。图像放大,有限的声窗,病变直径大于5 cm,衰减和图像模糊是在增强对比的美国对HPD进行假阳性诊断的主要原因。结论:采用增强对比的US可以可靠地检测FLL中的HPD,这与增强CT图像具有良好的相关性。 (c)RSNA,2011补充材料:http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11101454/-/DC1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号